BioSpace News Archive

Genetown

Ocean Biomedical (NASDAQ: OCEA) on World Malaria Day Announces Sharing of New Malaria Vaccine Paradigm at PATH Malaria Research Retreat in Washington, DC, by Scientific Co-founder Dr. Jonathan Kurtis

Ocean Biomedical, Inc. announced that its Scientific Co-founder, Jonathan Kurtis, MD, PhD, presented details of the Company’s novel malaria vaccine and treatment approach to malaria research scientists at PATH Malaria’s annual retreat in Washington, DC.

April 25, 2023

·

11 min read

Business

BIORCHESTRA Scientific Founder, Chairman, and Chief Executive Officer Joins the Republic of Korea (ROK) Official State Visit to the United States

BIORCHESTRA announced that the company’s Scientific Founder, Chairman, and Chief Executive Officer, Dr. Branden Ryu, has been invited by the Korean Government to join the Official State visit to the U.S.

April 25, 2023

·

5 min read

Genetown

Wren Therapeutics Renamed WaveBreak, Signifying Focus on Stopping the Wave of Neurodegeneration in Parkinson’s Disease, Alzheimer’s Disease, and ALS at its Source

Wren Therapeutics announced today that the company has changed its name to WaveBreak.

April 25, 2023

·

2 min read

Biotech Beach

bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium

bioAffinity Technologies, Inc. will present at the Cleveland Clinic’s invitation-only Advances in Early Lung Cancer Detection annual symposium in Cleveland, Ohio, on April 27, 2023.

April 25, 2023

·

3 min read

Biotech Bay

EnChroma and UNC’s Department of Health Sciences Team to Help Color Blind Students Address Challenges to Learning on Campus

EnChroma and the University of North Carolina at Chapel Hill’s Department of Health Sciences announced that special EnChroma glasses for color blindness will be available for students, faculty and staff who are Color Vision Deficient to borrow from the UNC Health Sciences Library and the UNC Davis Library to help them better navigate schoolwork that utilizes colors.

April 25, 2023

·

7 min read

Pharm Country

UroGen Pharma to Present at H.C. Wainwright BioConnect Conference

UroGen Pharma Ltd. today announced that it will participate in a fireside chat at the upcoming H.C. Wainwright BioConnect Conference on May 2, 2023 at 10:00 AM ET.

April 25, 2023

·

1 min read

Business

Corner Therapeutics Appoints Rick Malley, M.D., to Serve on Scientific Advisory Board

Corner Therapeutics today announced the appointment of Rick Malley, M.D., to their Scientific Advisory Board.

April 25, 2023

·

3 min read

Business

Juno Pharmaceuticals Partners With Rosemont Pharmaceuticals as Exclusive Canadian Distributor to Offer Previously Inaccessible Medicines

Juno Pharmaceuticals Canada announced its partnership with U.K. based developer, manufacturer and global supplier of novel, Rx, oral liquid medicines, Rosemont Pharmaceuticals (“Rosemont”), as its exclusive Canadian distributor.

April 25, 2023

·

3 min read

Business

Guardant Health and Parker Institute for Cancer Immunotherapy (PICI) launch research collaboration to study connection between cancer biomarkers and immunotherapy treatment response

Guardant Health, Inc. and the Parker Institute for Cancer Immunotherapy (PICI) today announced a research collaboration agreement to study the correlation between molecular cancer biomarkers and patient response to immunotherapy treatment across more than 14 different types of cancer.

April 25, 2023

·

6 min read

Genetown

Myrtelle’s rAAV-Olig001-ASPA Gene Therapy Candidate for Canavan Disease Receives Innovative Licensing and Access Pathway Designation from the UK Medicines and Healthcare Products Regulatory Agency

Myrtelle Inc today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA), the healthcare regulatory body of the United Kingdom (UK), granted Innovative Licensing and Access Pathway (ILAP) designation to the Company’s lead gene therapy product candidate, rAAV-Olig001-ASPA for the treatment of Canavan disease.

April 25, 2023

·

5 min read